Literature DB >> 15492172

Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.

Michael K Kim1, Susan H Mandel, Zubair Baloch, Virginia A Livolsi, Jill E Langer, Liesje Didonato, Stephanie Fish, Randal S Weber.   

Abstract

OBJECTIVE: To determine the incidence of recurrent laryngeal nerve injury and hypoparathyroidism, we reviewed our experience with central compartment reoperation.
DESIGN: Patients underwent preoperative ultrasonography and magnetic resonance imaging of the neck. Ultrasound-guided fine-needle aspiration biopsy was performed and demonstrated evidence of tumor in 15 patients. At the time of surgery, hook wire electrodes were placed endoscopically into 1 or both vocal cords to monitor the integrity of the recurrent laryngeal nerve. PATIENTS: The study population comprised 20 patients who had undergone reoperative central compartment dissections between the years 1997 and 2001. There were 15 women and 5 men whose mean age was 49.4 years. All of the patients had prior total or subtotal thyroidectomy, and 4 patients had prior neck dissections. A primary thyroid cancer recurrence in the thyroid bed was present in 7 patients, and the remainder of the patients had cytological evidence of paratracheal or mediastinal metastases. A single patient had evidence of distant metastases involving the lung. MAIN OUTCOME MEASURE: Short- and long-term postoperative morbidity.
RESULTS: Of the 20 patients, 18 had histologic evidence of metastases to the paratracheal lymph nodes, whereas 8 patients had metastases involving the anterior mediastinal lymph nodes. The mean number of lymph nodes removed was 6.5, and the mean number of positive lymph nodes was 4.7. None of the patients with normal preoperative laryngeal function had postoperative recurrent laryngeal nerve paresis or paralysis. There were 18 patients with normal preoperative parathyroid function. Four patients developed transient postoperative hypocalcemia. All 4 patients with transient postoperative hypocalcemia are currently eucalcemic. A single patient continues to receive calcium and calcitriol supplementation 1 month following her third central compartment dissection for recurrent thyroid cancer.
CONCLUSIONS: Reoperation for recurrent or persistent thyroid cancer presents a significant challenge. However, intraoperative recurrent laryngeal nerve monitoring and preservation of the vascular pedicle of the parathyroid glands has reduced the morbidity of reoperative central compartment dissections to acceptable levels. Revision surgery in the central compartment of the neck is compatible with successful eradication of recurrent thyroid cancers and acceptable morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15492172     DOI: 10.1001/archotol.130.10.1214

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  42 in total

1.  Surgeon-performed intraoperative tumor localization in recurrent papillary thyroid carcinoma by ultrasound-guided intratumoral indigo carmine injection.

Authors:  Dongbin Ahn; Jin Ho Sohn; Heejin Kim
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.

Authors:  Osama Al-Saif; William B Farrar; Mark Bloomston; Kyle Porter; Matthew D Ringel; Richard T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2010-03-23       Impact factor: 5.958

Review 3.  Surgical management of papillary thyroid carcinoma: an overview.

Authors:  Paolo Miccoli; Sohail Bakkar
Journal:  Updates Surg       Date:  2017-04-12

4.  Radioguided occult lesion localization for locally recurrent thyroid carcinoma.

Authors:  Mehmet Ali Gulcelik; Niyazi Karaman; Lutfi Dogan; Ilgın Sahiner; Gokhan Giray Akgul; Yavuz Selim Kahraman; Gulin Ucmak Vural
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-13       Impact factor: 2.503

5.  Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique.

Authors:  Oliver S Eng; Scott B Grant; Jason Weissler; Mitchell Simon; Sudipta Roychowdhury; Tomer Davidov; Stanley Z Trooskin
Journal:  Gland Surg       Date:  2016-12

6.  Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.

Authors:  Sae Rom Chung; Jung Hwan Baek; Young Jun Choi; Jeong Hyun Lee
Journal:  Eur Radiol       Date:  2019-02-25       Impact factor: 5.315

Review 7.  Central lymph node dissection in differentiated thyroid cancer.

Authors:  Matthew L White; Paul G Gauger; Gerard M Doherty
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

8.  Localization of recurrent thyroid cancer using intraoperative ultrasound-guided dye injection.

Authors:  Rebecca S Sippel; Dina M Elaraj; Liina Poder; Quan-Yang Duh; Electron Kebebew; Orlo H Clark
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

9.  Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.

Authors:  Gabriele Molteni; Marco Bonali; Francesco Mattioli; Michael Ghirelli; Matteo Fermi; Gaetano Ferri; Malagoli Andrea; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-10       Impact factor: 2.503

10.  Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; George C C Lee; Cathy P C Ng; Kai Pun Wong; Koon Yat Wan; Chung-Yau Lo
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.